Suppression of tumor growth, invasion an
β
DaniΓ«lle A. M. Heideman; Victor W. van Beusechem; Elisabeth Bloemena; Peter J. F
π
Article
π
2004
π
John Wiley and Sons
π
English
β 362 KB
## Abstract ## Background To improve the prognosis of patients with gastric cancer it is important to develop novel treatment modalities targeting the malignant behavior of tumor cells. Concerning this, NK4, which acts as HGFβantagonist and angiogenesis inhibitor, might be a potential therapeutic